Medicxi Ventures Management (Jersey) LTD has filed its 13F form on July 08, 2025 for Q2 2025 where it was disclosed a total value porftolio of $353 Million distributed in 5 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Centessa Pharmaceuticals PLC with a value of $262M, Phathom Pharmaceuticals, Inc. with a value of $71.6M, Aura Biosciences, Inc. with a value of $19M, Newamsterdam Pharma CO Nv Shs with a value of $0, and Rapt Therapeutics Inc with a value of $0.

Examining the 13F form we can see an decrease of $34.1M in the current position value, from $387M to 353M.

Below you can find more details about Medicxi Ventures Management (Jersey) LTD portfolio as well as his latest detailed transactions.

Portfolio value $353 Million
Healthcare: $353 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 5
  • Current Value $353 Million
  • Prior Value $387 Million
  • Filing
  • Period Q2 2025
  • Filing Date July 08, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Medicxi Ventures Management (Jersey) LTD Portfolio

Follow Medicxi Ventures Management (Jersey) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Medicxi Ventures Management (Jersey) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Medicxi Ventures Management (Jersey) LTD with notifications on news.